Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Pfizer
Roswell Park Cancer Institute
National Cancer Institute (NCI)
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Pfizer
NRG Oncology
Sun Yat-sen University